S291: LONG-TERM SAFETY AND EFFICACY OF CMV/EBV-SPECIFIC T CELLS FOR CMV AND EBV CO-REACTIVATION AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION

• Pei Xuying,
• Xiangyu Zhao,
• Meng LV,
• Jing Liu,
• Lanping Xu,
• Yu Wang,
• Xiao-Hui Zhang,
• Xiao-Jun Huang

Affiliations

Pei Xuying

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Xiangyu Zhao

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Meng LV

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Jing Liu

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Lanping Xu

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Yu Wang

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Xiao-Hui Zhang

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Xiao-Jun Huang

1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China